Suppression of Lymphocytes by Cephalosporins

  • E. A. Chaperon
Conference paper


The cephalosporins are a rapidly proliferating group of antimicrobial agents. They are widely used because they are similar to the penicillins in their structure and mode of action, but have the added advantages of being relatively resistant to the beta-lactamases and of possessing bactericidal activity against a broad spectrum of pathogenic microorganisms, many of which are not susceptible to the penicillins (11).


Lymphocyte Response Thymidine Uptake Febrile Neutropenic Patient Proliferate Group Delayed Hypersensitivity Response 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Barza, M. 1978. The nephrotoxicity of cephalosporins; an overview. J. Infect. Dis. 137(Suppl.):S60–S73.PubMedCrossRefGoogle Scholar
  2. 2.
    Berger, S., E. C. Ernst, and M. Borza. 1976. Comparative incidence of phlebitis due to buffered cephalothin, cephapirin and cefamandole. Antimicrob. Agents Chemother. 9:575–579.PubMedGoogle Scholar
  3. 3.
    Chaperon, E. A., and W. E. Sanders, Jr. 1978. Suppression of lymphocyte responses by cephalosporins. Infect. Immun. 19: 378–384.PubMedGoogle Scholar
  4. 4.
    Chaperon, E. A., M. Degen, and W. E. Sanders, Jr. 1980. Suppressive effect of cephalosporins on thymidine incorporation by human lymphocytes, p. 836–838. In J. D. Nelson and C. Grassi (ed.), Current Chemotherapy and Infectious Disease — 1978. American Society for Microbiology, Washington, D.C..Google Scholar
  5. 5.
    Fischer, A., A. Durandy, and C. Griscelli. 1981. Role of prostaglandin E2 in the induction of nonspecific T lymphocyte suppressor activity. J. Immunol. 126:1452–1455.PubMedGoogle Scholar
  6. 6.
    Goodwin, J. S., A. D. Bankhurst, and R. P. Messner. 1977. Suppression of human T-cell mitogenesis by prostaglandins. J. Exp. Med. 146:1719–1734.PubMedCrossRefGoogle Scholar
  7. 7.
    Kosakai, N., and C. Miyakawa. 1970. Fundamental studies on the positive Coombs— tests due to cephalosporins. Postgrad. Med. J. 46(Suppl.): 107–116.Google Scholar
  8. 8.
    Larson, S. E., C. Collins-Lech, and P. G. Sohnle. 1980. Effect of antibiotics on lymphokine production, p. 838–839. In J. D. Nelson and C. Grassi (ed.). Current Chemotherapy and Infectious Disease — 1979. American Society for Microbiology, Washington, D.C..Google Scholar
  9. 9.
    Murray, B. E., and R. C. Moellering. 1981. Cephalosporins. Ann. Rev. Med. 32: 559–581.PubMedCrossRefGoogle Scholar
  10. 10.
    Natelson, E. A., C. H. Brown, III, M. W. Bradshaw, C. P. Alfrey, Jr., and T. W. Williams, Jr. 1976. Influence of cephalosporin antibiotics on coagulation and platelet function. Antimicrob. Agents Chemother. 9:91–93.PubMedGoogle Scholar
  11. 11.
    O’Callaghan, C. H. 1979. Description and classification of the newer cephalosporins and their relation with the established compounds. J. Antimicrob. Chemother. 5:635–671.PubMedCrossRefGoogle Scholar
  12. 12.
    Petz, L. D. 1971. Immunologic reactions of humans to cephalosporins. Postgrad. Med. J. 47 (Suppl.): 64–67.PubMedGoogle Scholar
  13. 13.
    Petz, L. D. 1978. Immunologic cross-reactivity between penicillins and cephalosporins: a review. J. Infect. Dis. 137 (Suppl.): S 74–S 87.Google Scholar
  14. 14.
    Rubin, R. N., and E. R. Burke. 1977. Anti cephalothin antibody and Coombs’ positive hemolytic anemia. Ann. Intern. Med. 86: 64–65.PubMedGoogle Scholar
  15. 15.
    Sanders, W. E., Jr., J. E. Johnson, and J. G. Taggart. 1974. Adverse reactions to cephalothin and cephapirin: uniform occurrence in prolonged intravenous administration of high doses. N. Engl. J. Med. 290: 424–429.PubMedCrossRefGoogle Scholar
  16. 16.
    Tadakuma, T., and C. W. Pierce. 1976. Site of action of a soluble immune response suppressor (SIRS) produced by concanavalin A-activated spleen cells. J. Immunol. 117:961–912, 1976Google Scholar
  17. 17.
    Thorsby, E., and A. Bratlie. 1970. A rapid method for preparation of pure lymphocyte suspensions. p. 655–656. In P. I. Terasaki (ed.), Histocompatibility testing. Munksgaard. Copenhagen.Google Scholar
  18. 18.
    Waksman, B. H., and Y. Namba. 1976. On soluble mediators of immunologic regulation. Cell. Immunol. 21:161–176.PubMedCrossRefGoogle Scholar
  19. 19.
    Webb, D. R., and I. Nowowiejski. 1978. Mitogen-induced changes in lymphocyte prostaglandin levels: A signal for the induction of suppressor cell activity. Cell. Immunol. 41:72–85.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 1982

Authors and Affiliations

  • E. A. Chaperon
    • 1
  1. 1.Department of Medical MicrobiologyCreighton University, School of MedicineOmahaUSA

Personalised recommendations